Tags

Type your tag names separated by a space and hit enter

Endogenous opiates and behavior: 2012.
Peptides. 2013 Dec; 50:55-95.P

Abstract

This paper is the thirty-fifth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2012 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17).

Authors+Show Affiliations

Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, NY 11367, United States. Electronic address: richard.bodnar@qc.cuny.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24126281

Citation

Bodnar, Richard J.. "Endogenous Opiates and Behavior: 2012." Peptides, vol. 50, 2013, pp. 55-95.
Bodnar RJ. Endogenous opiates and behavior: 2012. Peptides. 2013;50:55-95.
Bodnar, R. J. (2013). Endogenous opiates and behavior: 2012. Peptides, 50, 55-95. https://doi.org/10.1016/j.peptides.2013.10.001
Bodnar RJ. Endogenous Opiates and Behavior: 2012. Peptides. 2013;50:55-95. PubMed PMID: 24126281.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Endogenous opiates and behavior: 2012. A1 - Bodnar,Richard J, Y1 - 2013/10/12/ PY - 2013/10/01/received PY - 2013/10/01/accepted PY - 2013/10/16/entrez PY - 2013/10/16/pubmed PY - 2014/7/16/medline KW - 5-HT KW - ACTH KW - ANG KW - ATP KW - Ach KW - BAM22 KW - BDNF KW - BEND KW - BFNA KW - BNST KW - Beta-endorphin KW - C/P KW - CART KW - CB KW - CCK KW - CGRP KW - CPP KW - CRF KW - CTAP KW - Ca(2+) KW - DA KW - DADL KW - DAMGO KW - DOR KW - DPDPE KW - DRG KW - DRN KW - DYN KW - Dynorphin, Orphanin FQ/nociceptin KW - ERK KW - Endomorphins KW - Enk KW - Enkephalins KW - FMRI KW - FSH KW - G-protein-coupled receptor kinases KW - GABA KW - GHRH KW - GI KW - GRK KW - HIV KW - HPA KW - HPLC KW - ICSS KW - K(+) KW - KO KW - KOR KW - LC KW - LH KW - LPS KW - LTP KW - Lenk KW - M3G KW - M6G KW - MAPK KW - MCH KW - MOR KW - MSH KW - Menk KW - N-methyl-d-aspartate KW - NAC KW - NBNI KW - NE KW - NMDA KW - NO KW - NOS KW - NPY KW - NTI KW - NTS KW - Na+ KW - OFQ/N KW - ORL-1 KW - OXY KW - Opiate receptors KW - PAG KW - PBN KW - PCA KW - PDYN KW - PKA KW - PKC KW - POFQ/N KW - POMC KW - PTSD KW - PVN KW - Penk KW - RVM KW - SIA KW - SNP KW - SP KW - STZ KW - THC KW - TMJ KW - TNF KW - VMH KW - VP KW - VTA KW - acetylcholine KW - adenosine triphosphate KW - adrenocorticotrophic hormone KW - angiotensin KW - bed nucleus of the stria terminalis KW - beta-endorphin KW - beta-funaltrexamine KW - bovine adrenal medulla 22 KW - brain-derived neurotrophic factor KW - calcitonin gene-related peptide KW - calcium KW - cannabinoid KW - caudate/putamen KW - cholecystokinin KW - cocaine and amphetamine-regulated transcript KW - conditioned place preference KW - corticotropin factor KW - d-Ala(2),Nme(4),Gly-ol(5)-enkephalin KW - d-Ala(2),d-Leu(5)-enkephalin KW - d-Pen(2),d-Pen(5)-enkephalin KW - d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2 cyclic KW - delta opioid receptor KW - dopamine KW - dorsal raphe nucleus KW - dorsal root ganglion KW - dynorphin KW - enkephalin KW - extracellular regulated signal kinases KW - follicle stimulating hormone KW - functional magnetic resonance imaging KW - gamma-amino-butyric acid KW - gastrointestinal KW - growth hormone releasing hormone KW - high-performance liquid chromatography KW - human immunodeficiency virus KW - hypothalamus–pituitary–adrenal KW - intracranial self-stimulation KW - kappa opioid receptor KW - knockout KW - l-3,4-dihydroxyphenylalanine KW - l-DOPA KW - leu-enkephalin KW - leutinizing hormone KW - lipopolysaccharide KW - locus coeruleus KW - long-term potentiation KW - melanin concentrating hormone KW - melanocyte stimulating hormone KW - met-enkephalin KW - mitogen-activated protein kinase KW - morphine-3-glucuronide KW - morphine-6-glucuronide KW - mu opioid receptor KW - naltrindole KW - neuropeptide Y KW - nitric oxide KW - nitric oxide synthase KW - nociceptin KW - nor-binaltorphamine KW - norepinephrine KW - nucleus accumbens KW - nucleus tractus solitarius KW - orphan receptor like receptor KW - oxytocin KW - parabrachial nucleus KW - paraventricular nucleus KW - patient-controlled analgesia KW - periaqueductal gray KW - post-traumatic stress disorder KW - potassium KW - preprodynorphin KW - preproenkephalin KW - prepronociceptin/orphanin FQ KW - pro-opiomelanocortin KW - protein kinase A KW - protein kinase C KW - rostral ventromedial medulla KW - serotonin KW - single nucleotide polymorphism KW - sodium KW - streptozotocin KW - stress-induced analgesia KW - substance P KW - temporomandibular joint KW - tetrahydrocannibinol KW - tumor necrosis factor KW - vasopressin KW - ventral tegmental area KW - ventromedial nucleus of the hypothalamus SP - 55 EP - 95 JF - Peptides JO - Peptides VL - 50 N2 - This paper is the thirty-fifth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2012 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17). SN - 1873-5169 UR - https://www.unboundmedicine.com/medline/citation/24126281/Endogenous_opiates_and_behavior:_2012_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0196-9781(13)00333-1 DB - PRIME DP - Unbound Medicine ER -